US Stock MarketDetailed Quotes

AUGX Augmedix

Watchlist
  • 2.290
  • +0.010+0.44%
Close Aug 23 16:00 ET
  • 2.290
  • 0.0000.00%
Post 20:01 ET
112.77MMarket Cap-4872P/E (TTM)

Augmedix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
36.03%-3.81M
-32.39%-8.24M
7.94%-15.44M
77.82%-973K
35.06%-2.29M
-26.76%-5.95M
-49.58%-6.22M
9.78%-16.77M
16.96%-4.39M
35.29%-3.53M
Net income from continuing operations
-67.89%-8.45M
-24.05%-6.5M
21.59%-19.17M
19.77%-4.49M
19.73%-4.41M
31.38%-5.03M
13.05%-5.24M
-40.00%-24.45M
-6.08%-5.6M
-107.56%-5.49M
Operating gains losses
---6K
--55K
-94.14%64K
-920.00%-41K
--36K
----
----
154.52%1.09M
-68.75%5K
--0
Depreciation and amortization
58.78%416K
57.35%439K
28.27%1.1M
22.89%306K
15.14%251K
21.86%262K
60.34%279K
23.88%856K
48.21%249K
39.74%218K
Other non cash items
29.90%504K
60.20%487K
27.38%1.74M
160.85%553K
38.27%495K
17.58%388K
-34.76%304K
10.52%1.37M
-60.37%212K
28.78%358K
Change In working capital
209.25%2.46M
-76.59%-3.67M
-182.41%-1.82M
45,325.00%1.82M
-23.70%689K
-536.70%-2.25M
-363.29%-2.08M
192.75%2.21M
100.38%4K
162.84%903K
-Change in receivables
119.29%610K
-2,648.28%-1.48M
-405.09%-2.4M
154.95%727K
94.43%-20K
-548.16%-3.16M
-98.04%58K
117.74%786K
16.37%-1.32M
79.68%-359K
-Change in prepaid assets
158.27%155K
-46.24%-623K
-3,970.59%-692K
49.15%-60K
-82.56%60K
5.34%-266K
-1,221.05%-426K
97.99%-17K
90.47%-118K
739.02%344K
-Change in payables and accrued expense
364.25%2.12M
-17.24%-1.32M
-79.97%253K
-94.74%39K
27.42%883K
-47.65%456K
-7.86%-1.13M
-49.76%1.26M
-44.75%742K
-10.23%693K
-Change in other current liabilities
-48.34%-313K
-39.45%-304K
-30.87%-992K
-83.61%-224K
-28.90%-339K
-11.64%-211K
-18.48%-218K
---758K
---122K
---263K
-Change in other working capital
-111.98%-112K
113.82%51K
113.86%2.01M
61.82%1.34M
-78.48%105K
55.32%935K
62.23%-369K
148.15%938K
98.80%825K
201.04%488K
Cash from discontinued investing activities
Operating cash flow
36.03%-3.81M
-32.39%-8.24M
7.94%-15.44M
77.82%-973K
35.06%-2.29M
-26.76%-5.95M
-49.58%-6.22M
9.78%-16.77M
16.96%-4.39M
35.29%-3.53M
Investing cash flow
Cash flow from continuing investing activities
72.27%-361K
-213.29%-542K
-120.53%-3.11M
-101.52%-1.19M
-117.41%-437K
-703.70%-1.3M
61.81%-173K
-130.44%-1.41M
-214.89%-592K
-91.43%-201K
Net PPE purchase and sale
72.27%-361K
-213.29%-542K
-120.53%-3.11M
-101.52%-1.19M
-117.41%-437K
-703.70%-1.3M
61.81%-173K
-130.44%-1.41M
-214.89%-592K
-91.43%-201K
Cash from discontinued investing activities
Investing cash flow
72.27%-361K
-213.29%-542K
-120.53%-3.11M
-101.52%-1.19M
-117.41%-437K
-703.70%-1.3M
61.81%-173K
-130.44%-1.41M
-214.89%-592K
-91.43%-201K
Financing cash flow
Cash flow from continuing financing activities
-99.38%74K
-98.84%59K
3,606.06%43.37M
376,771.43%26.38M
400.00%20K
1,042.43%11.88M
39,015.38%5.09M
-103.27%-1.24M
-99.98%7K
233.33%4K
Net issuance payments of debt
--0
--0
544.44%5M
--0
--0
--0
--5M
-155.31%-1.13M
--0
--0
Net common stock issuance
----
----
--38.74M
--26.93M
---36K
----
----
--0
--0
--0
Proceeds from stock option exercised by employees
63.83%154K
-30.59%59K
1,083.33%355K
1,614.29%120K
1,300.00%56K
1,466.67%94K
553.85%85K
-80.77%30K
-82.05%7K
-69.23%4K
Net other financing activities
----
----
-407.04%-720K
---665K
--0
----
----
96.75%-142K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-99.38%74K
-98.84%59K
3,606.06%43.37M
376,771.43%26.38M
400.00%20K
1,042.43%11.88M
39,015.38%5.09M
-103.27%-1.24M
-99.98%7K
233.33%4K
Net cash flow
Beginning cash position
82.35%37.64M
110.76%46.34M
-47.13%21.99M
-17.45%22.29M
-17.93%25.26M
-44.19%20.64M
-47.13%21.99M
81.03%41.59M
142.82%27M
84.47%30.78M
Current changes in cash
-188.50%-4.1M
-566.08%-8.72M
227.84%24.82M
587.13%24.22M
27.31%-2.71M
175.62%4.63M
71.54%-1.31M
-204.26%-19.42M
-116.31%-4.97M
33.01%-3.73M
Effect of exchange rate changes
-1,500.00%-112K
130.00%12K
-159.67%-470K
-318.42%-159K
-398.11%-264K
91.86%-7K
-900.00%-40K
-1,710.00%-181K
-442.86%-38K
-2,550.00%-53K
End cash Position
32.33%33.43M
82.35%37.64M
110.76%46.34M
110.76%46.34M
-17.45%22.29M
-17.93%25.26M
-44.19%20.64M
-47.13%21.99M
-47.13%21.99M
142.82%27M
Free cash flow
42.52%-4.17M
-37.69%-8.8M
-2.01%-18.55M
56.49%-2.17M
26.85%-2.73M
-49.33%-7.26M
-38.64%-6.39M
5.32%-18.18M
8.99%-4.98M
32.90%-3.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 36.03%-3.81M-32.39%-8.24M7.94%-15.44M77.82%-973K35.06%-2.29M-26.76%-5.95M-49.58%-6.22M9.78%-16.77M16.96%-4.39M35.29%-3.53M
Net income from continuing operations -67.89%-8.45M-24.05%-6.5M21.59%-19.17M19.77%-4.49M19.73%-4.41M31.38%-5.03M13.05%-5.24M-40.00%-24.45M-6.08%-5.6M-107.56%-5.49M
Operating gains losses ---6K--55K-94.14%64K-920.00%-41K--36K--------154.52%1.09M-68.75%5K--0
Depreciation and amortization 58.78%416K57.35%439K28.27%1.1M22.89%306K15.14%251K21.86%262K60.34%279K23.88%856K48.21%249K39.74%218K
Other non cash items 29.90%504K60.20%487K27.38%1.74M160.85%553K38.27%495K17.58%388K-34.76%304K10.52%1.37M-60.37%212K28.78%358K
Change In working capital 209.25%2.46M-76.59%-3.67M-182.41%-1.82M45,325.00%1.82M-23.70%689K-536.70%-2.25M-363.29%-2.08M192.75%2.21M100.38%4K162.84%903K
-Change in receivables 119.29%610K-2,648.28%-1.48M-405.09%-2.4M154.95%727K94.43%-20K-548.16%-3.16M-98.04%58K117.74%786K16.37%-1.32M79.68%-359K
-Change in prepaid assets 158.27%155K-46.24%-623K-3,970.59%-692K49.15%-60K-82.56%60K5.34%-266K-1,221.05%-426K97.99%-17K90.47%-118K739.02%344K
-Change in payables and accrued expense 364.25%2.12M-17.24%-1.32M-79.97%253K-94.74%39K27.42%883K-47.65%456K-7.86%-1.13M-49.76%1.26M-44.75%742K-10.23%693K
-Change in other current liabilities -48.34%-313K-39.45%-304K-30.87%-992K-83.61%-224K-28.90%-339K-11.64%-211K-18.48%-218K---758K---122K---263K
-Change in other working capital -111.98%-112K113.82%51K113.86%2.01M61.82%1.34M-78.48%105K55.32%935K62.23%-369K148.15%938K98.80%825K201.04%488K
Cash from discontinued investing activities
Operating cash flow 36.03%-3.81M-32.39%-8.24M7.94%-15.44M77.82%-973K35.06%-2.29M-26.76%-5.95M-49.58%-6.22M9.78%-16.77M16.96%-4.39M35.29%-3.53M
Investing cash flow
Cash flow from continuing investing activities 72.27%-361K-213.29%-542K-120.53%-3.11M-101.52%-1.19M-117.41%-437K-703.70%-1.3M61.81%-173K-130.44%-1.41M-214.89%-592K-91.43%-201K
Net PPE purchase and sale 72.27%-361K-213.29%-542K-120.53%-3.11M-101.52%-1.19M-117.41%-437K-703.70%-1.3M61.81%-173K-130.44%-1.41M-214.89%-592K-91.43%-201K
Cash from discontinued investing activities
Investing cash flow 72.27%-361K-213.29%-542K-120.53%-3.11M-101.52%-1.19M-117.41%-437K-703.70%-1.3M61.81%-173K-130.44%-1.41M-214.89%-592K-91.43%-201K
Financing cash flow
Cash flow from continuing financing activities -99.38%74K-98.84%59K3,606.06%43.37M376,771.43%26.38M400.00%20K1,042.43%11.88M39,015.38%5.09M-103.27%-1.24M-99.98%7K233.33%4K
Net issuance payments of debt --0--0544.44%5M--0--0--0--5M-155.31%-1.13M--0--0
Net common stock issuance ----------38.74M--26.93M---36K----------0--0--0
Proceeds from stock option exercised by employees 63.83%154K-30.59%59K1,083.33%355K1,614.29%120K1,300.00%56K1,466.67%94K553.85%85K-80.77%30K-82.05%7K-69.23%4K
Net other financing activities ---------407.04%-720K---665K--0--------96.75%-142K--0--0
Cash from discontinued financing activities
Financing cash flow -99.38%74K-98.84%59K3,606.06%43.37M376,771.43%26.38M400.00%20K1,042.43%11.88M39,015.38%5.09M-103.27%-1.24M-99.98%7K233.33%4K
Net cash flow
Beginning cash position 82.35%37.64M110.76%46.34M-47.13%21.99M-17.45%22.29M-17.93%25.26M-44.19%20.64M-47.13%21.99M81.03%41.59M142.82%27M84.47%30.78M
Current changes in cash -188.50%-4.1M-566.08%-8.72M227.84%24.82M587.13%24.22M27.31%-2.71M175.62%4.63M71.54%-1.31M-204.26%-19.42M-116.31%-4.97M33.01%-3.73M
Effect of exchange rate changes -1,500.00%-112K130.00%12K-159.67%-470K-318.42%-159K-398.11%-264K91.86%-7K-900.00%-40K-1,710.00%-181K-442.86%-38K-2,550.00%-53K
End cash Position 32.33%33.43M82.35%37.64M110.76%46.34M110.76%46.34M-17.45%22.29M-17.93%25.26M-44.19%20.64M-47.13%21.99M-47.13%21.99M142.82%27M
Free cash flow 42.52%-4.17M-37.69%-8.8M-2.01%-18.55M56.49%-2.17M26.85%-2.73M-49.33%-7.26M-38.64%-6.39M5.32%-18.18M8.99%-4.98M32.90%-3.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg